Détail de l'auteur
Auteur M. HICKMAN |
Documents disponibles écrits par cet auteur (89)
Article : Périodique
J. M. KESTEN ; R. AYRES ; J. NEALE ; J. CLARK ; P. VICKERMAN ; M. HICKMAN ; S. REDWOOD |Background: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]NouveautéArticle : Périodique
R. MELOTTI ; J. HERON ; M. HICKMAN ; J. MACLEOD ; R. ARAYA ; G. LEWIS |Objective: To examine the association between use of alcohol and cigarettes among adolescents and their early socioeconomic background. Methods: Members of a longitudinal birth cohort (Avon Longitudinal Study of Parents and Children [ALSPAC], Un[...]Article : Périodique
A. I. STIBY ; M. HICKMAN ; M. R. MUNAFO ; J. HERON ; V. L. YIP ; J. MACLEOD |Aims: To investigate the relationship between cannabis and tobacco use by age 15 and subsequent educational outcomes. Design: Birth cohort study. Setting: England. Participants: The sample was drawn from the Avon Longitudinal Study of Parents[...]Article : Périodique
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT |BACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]Périodique
C. ACEIJAS ; E. OPPENHEIMER ; G. V. STIMSON ; R. E. ASHCRAFT ; S. MATIC ; M. HICKMAN | 2006Objective: To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries. Methods: Literature review of grey and published literature and key informants' commu[...]Article : Périodique
C. ANGUS ; R. PRYCE ; J. HOLMES ; F. DE VOCHT ; M. HICKMAN ; P. MEIER ; A. BRENNAN ; D. GILLESPIE |BACKGROUND AND AIMS: When measuring inequalities in health, public health and addiction research has tended to focus on differences in average life-span between socio-economic groups. This does not account for the extent to which age of death va[...]Périodique
O. MORGAN ; C. GRIFFITHS ; M. HICKMAN | 2007ENGLISH : BACKGROUND: The UK heroin market is the biggest in Europe and approximately 70% of heroin deaths are due to fatal poisoning. Methadone treatment for heroin addiction in the UK, the 'British system', is unique as it is largely provide[...]Article : Périodique
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY |BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]Article : Périodique
C. M. COMISKEY ; A. L. BRETTEVILLE-JENSEN ; H. BERGERON ; G. BUHRINGER ; P. DARGAN ; M. DAVOLI ; F. FAGGIANO ; G. FISCHER ; F. RODRIGUEZ DE FONSECA ; H. GARRETSEN ; M. HICKMAN ; D. J. KORF ; K. KRAJEWSKI ; L. PAOLI ; R. SPANAGEL |With the breadth of new psychoactive substances and international policy changes, an analysis of specific responses in all areas of drug supply and demand is beyond the resources of a single country. The Scientific Committee of the European Moni[...]Article : Périodique
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL |Background: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]Article : Périodique
Aims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]Périodique
V. D. HOPE ; M. HICKMAN ; K. TILLING | 2005ENGLISH : Aim : To estimate the prevalence of crack cocaine use in 12 London Boroughs (and London as a whole). Setting : Twelve London Boroughs, 2000-01. Methods : (1) Covariate capture-recapture techniques applied to three data sources of sub[...]Article : Périodique
BACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]Périodique
M. FRISCHER ; M. HICKMAN ; L. KRAUS ; F. MARIANI ; L. WIESSING | 2001ENGLISH : Aims. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and pro[...]Article : Périodique
N. GOULDING ; M. HICKMAN ; M. REID ; E. J. AMUNDSEN ; J. A. BAZ-LOMBA ; J. W. O'BRIEN ; B. J. TSCHARKE ; P. DE VOOGT ; E. EMKE ; W. KUIJPERS ; W. HALL ; H. E. JONES |AIMS: To compare long-term trends in wastewater data with other indicators of stimulant use in three locations and to test the reliability of estimates based on 1 week of sampling. DESIGN: Comparison of trends in quantities ('loads') of stimula[...]Article : Périodique
R. MCGOVERN ; L. CROWE ; M. ADDISON ; M. HICKMAN ; J. KIDGER ; E. MCCOLL ; D. NEWBURY-BIRCH ; E. KANER |Heavy alcohol use and associated needs are prevalent amongst arrestees. The custody suite offers an opportunity to identify and intervene with this population. However, it is unclear whether functions of care can be effectively delivered within [...]Périodique
M. HICKMAN ; M. GRIFFIN ; J. MOTT ; J. CORKERY ; P. MADDEN ; SONDHI A. ; G. STIMSON | 2004ENGLISH : Aims : We discuss the Addicts Index (AI) and examine whether the epidemiological trends of the AI can be continued by the regional drug misuse databases (DMDs, now known as National Drug Treatment Monitoring System (NDTMS). Methods :[...]Article : Périodique
Studies published by Zule and colleagues have suggested that use of low dead-space syringes (LDSS) instead of high dead-space syringes (HDSS) by injecting drug users (IDUs) could dramatically reduce HIV transmission. However, evidence is limited[...]Article : Périodique
S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT |There is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]Article : Périodique
E. HANCOCK ; Z. WARD ; R. AYRES ; J. NEALE ; D. HUSSEY ; J. M. KESTEN ; M. HICKMAN ; P. VICKERMAN |BACKGROUND AND AIMS: Traditional detachable syringes used by people who inject drugs (PWID) retain larger volumes of blood when the plunger is depressed than syringes with fixed needles-referred to as high (HDSS) and low dead space syringes (LDS[...]Périodique
M. FRISHER ; S. ANDERSON ; M. HICKMAN ; HEATLIE H. | 2002Despite qualitative accounts of the spread of drug misuse in the UK there has been little epidemiological analysis of drug diffusion in recent years. This study used the data from the 1993 and 1996 Scottish Crime Surveys to investigate whether t[...]Article : Périodique
J. MARSDEN ; G. STILLWELL ; H. JONES ; A. COOPER ; B. EASTWOOD ; M. FARRELL ; T. LOWDEN ; N. MADDALENA ; C. METCALFE ; J. SHAW ; M. HICKMAN |Background and Aims: People with opioid use disorder (OUD) in prison face an acute risk of death after release. We estimated whether prison-based opioid substitution treatment (OST) reduces this risk. Design Prospective observational cohort stud[...]Article : Périodique
A. M. BARGAGLI ; M. HICKMAN ; M. DAVOLI ; C. A. PERUCCI ; P. SCHIFANO ; M. BUSTER ; T. BRUGAL ; J. VICENTE |ENGLISH : Objective: To estimate the mortality rates from drug-related deaths and other causes among problem drug users and population attributable risk of death due to opiate use in eight study sites in Europe. Methods: Opiate users were recr[...]Périodique
SCHIER J. G. ; L. S. NELSON ; R. S. HOFFMAN ; P. CUMMINGS ; J. MACLEOD ; M. HICKMAN ; G. D. SMITH ; K. J. S. ANAND ; M. T. LYNSKEY ; D. J. STATHAM ; N. G. MARTIN ; A. C. HEATH ; K. K. BUCHOLZ ; P. A. F. MADDEN ; E. C. NELSON ; W. S. SLUTSKE | 2003FRANÇAIS : Lettres à l'éditeur à propos de l'étude de "Escalation of drug use in early-onset cannabis users vs co-twins controls" publié dans JAMA, 2003, 289, 427-433, remettant en cause les résultats de cette étude.Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Article : Périodique
Objectif de la revue : Les interventions psychosociales sont des interventions verbales ou pratiques, ou les deux, dispensées à des individus ou à des groupes. Les interventions examinées dans cette revue cherchent à aider les parents à modifie[...]Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017Livre
Z. SLOBODA ; E. M. ADLAF ; M. D. ANGLIN ; M. L. BRECHT ; J. D. COLLIVER ; K. P. CONWAY ; D. C. DES JARLAIS ; K. W. ELIFSON ; S. R. FRIEDMAN ; C. FRY ; M. D. GLANTZ ; P. GRIFFITHS ; H. HAGAN ; W. HALL ; M. HICKMAN ; Y. I. HSER ; R. L. HUBBARD ; N. J. KOZEL ; T. LOCKE ; D. LONGSHORE ; R. McKETIN ; M. D. NEWCOMB ; J. A. RESKO ; C. E. STERK ; C. TAYLOR ; C. WALKER ; T. A. WILLS | New York : Springer Inc. | 2005ENGLISH : As the drug abuse epidemic evolves, so do the tools needed to understand and treat it. Accordingly, Epidemiology of Drug Abuse takes the long view, cogently outlining what the book calls "the natural history of drug abuse" and redefi[...]Article : Périodique
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY |BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]Périodique
C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN | 2006ENGLISH : OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature r[...]Article : Périodique
D. DE ANGELIS ; M. HICKMAN ; S. YANG |The authors explored an age-specific back-calculation approach to estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use (IDU) in England for 1968-2000. The incidence of opiate use/IDU was estimated by combi[...]Article : Périodique
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT |Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]Article : Périodique
H. E. JONES ; R. J. HARRIS ; B. C. DOWNING ; M. PIERCE ; T. MILLAR ; A. E. ADES ; N. J. WELTON ; A. M. PRESANIS ; D. DE ANGELIS ; M. HICKMAN |BACKGROUND AND AIMS: Indirect estimation methods are required for estimating the size of populations where only a proportion of individuals are observed directly, such as problem drug users (PDUs). Capture-recapture and multiplier methods are wi[...]Périodique
M. HICKMAN ; S. COX ; HARVEY J. ; S. HOWES ; M. FARRELL ; M. FRISCHER ; G. STIMSON ; C. TAYLOR ; K. TILLING | 1999FRANÇAIS : Objectifs : fournir une base sûre pour estimer la prévalence de l'usage de drogues dans le centre de Londres. Etude : revue de trois études portant sur un échantillon de sujets âgés de 15 à 49 ans, dans le but d'estimer la population[...]Article : Périodique
M. HICKMAN ; SEAMAN S. ; D. DE ANGELIS |In this paper, the authors propose a method for estimating the incidence of heroin use by adjusting reported numbers of heroin users visiting drug treatment agencies for the time lag between onset of heroin use and first treatment request (lag d[...]Périodique
M. HICKMAN ; C. TAYLOR ; A. CHATTERJEE ; L. DEGENHARDT ; M. FRISCHER ; G. HAY ; K. TILLING ; L. WIESSING ; P. GRIFFITHS ; R. McKETIN | 2002Les décideurs ont de plus en plus besoin d'estimations de la prévalence de la consommation problématique de drogues, comme l'usage par voie intraveineuse et la consommation de "crack". Dans cet article, les auteurs passent en revue les méthodes [...]Article : Périodique
S. SWEENEY ; Z. WARD ; L. PLATT ; L. GUINNESS ; M. HICKMAN ; V. HOPE ; L. MAHER ; J. IVERSEN ; S. J. HUTCHINSON ; J. SMITH ; R. AYRES ; I. HAINEY ; P. VICKERMAN |AIM: To evaluate the cost-effectiveness of needle and syringe programmes (NSPs) compared with no NSPs on hepatitis C virus (HCV) transmission in the United Kingdom. DESIGN: Cost-effectiveness analysis from a National Health Service (NHS)/healt[...]Article : Périodique
A. JUDD ; J. PARRY ; M. HICKMAN ; T. McDONALD ; L. JORDAN ; K. LEWIS ; CONTRERAS M. ; DUSHEIKO G. ; G. FOSTER ; N. GILL ; K. KEMP ; J. MAIN ; I. MURRAY-LYON ; M. NELSON |Oral fluid testing is an effective alternative to serum antibody testing for surveillance of human immunodeficiency virus (HIV) and hepatitis B infections, and is being extended to hepatitis C infections. The objective of this study was to deter[...]Article : Périodique
N. E. PALMATEER ; J. KIMBER ; M. HICKMAN ; S. HUTCHINSON ; T. RHODES ; D. GOLDBERG |AIMS: To review the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injec[...]Périodique
T. RHODES ; LOWNDES C. ; A. JUDD ; MIKHAILOVA L. A. ; SARANG A. ; RYLKOV A. ; TICHONOV M. ; K. LEWIS ; ULYANOVA N. ; T. ALPATOVA ; KARAVASHKIN V. ; KHUTORSKOY M. ; M. HICKMAN ; J. V. PARRY ; A. RENTON | 2002ENGLISH : Objective: To establish the prevalence of antibodies to HIV (anti-HIV) and associated risk factors among injecting drug users (IDU) in Togliatti City, Samara Oblast, Russian Federation. Design: An unlinked anonymous cross-sectional c[...]Article : Périodique
V. D. HOPE ; M. HICKMAN ; J. V. PARRY ; F. NCUBE |BACKGROUND: People who inject drugs (PWID) are at risk of injection site infections and injuries. The factors associated with recent symptoms of these problems are examined. METHOD: PWID recruited using respondent driven sampling, underwent a [...]Article : Périodique
V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE |BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]Article : Périodique
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT |BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]Article : Périodique
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT |BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Article : Périodique
J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY |BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]Périodique
C. ACEIJAS ; G. V. STIMSON ; M. HICKMAN ; T. RHODES | 2004ENGLISH : Objective: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries. Methods: Collation and review of existin[...]Article : Périodique
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY |We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]Article : Périodique
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY |Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT |Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]